amifostine anhydrous has been researched along with Rectal Diseases in 2 studies
Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.
Rectal Diseases: Pathological developments in the RECTUM region of the large intestine (INTESTINE, LARGE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kouloulias, VE | 2 |
| Kouvaris, JR | 2 |
| Pissakas, G | 1 |
| Kokakis, JD | 1 |
| Antypas, C | 1 |
| Mallas, E | 1 |
| Matsopoulos, G | 1 |
| Michopoulos, S | 1 |
| Vosdoganis, SP | 1 |
| Kostakopoulos, A | 1 |
| Vlahos, LJ | 1 |
1 review available for amifostine anhydrous and Rectal Diseases
| Article | Year |
|---|---|
Cytoprotective efficacy of amifostine against radiation- induced rectal toxicity: objective and subjective grading scales for radiomucositis.
Topics: Amifostine; Cytoprotection; Endpoint Determination; Humans; Radiation; Rectal Diseases; Treatment Ou | 2008 |
1 trial available for amifostine anhydrous and Rectal Diseases
| Article | Year |
|---|---|
A phase II randomized study of topical intrarectal administration of amifostine for the prevention of acute radiation-induced rectal toxicity.
Topics: Administration, Rectal; Administration, Topical; Aged; Amifostine; Feasibility Studies; Humans; Inte | 2004 |